14-day Premium Trial Subscription Sign Up For FreeGet Free

Bellerophon Therapeutics Stock Forecast NASDAQ:BLPH

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about BLPH and gave it a "Buy" rating on November 06, 2020. The price target was set to $22.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-06-23 Buy Reiterated by Brookline Capital Management $5.32
2020-11-06 Buy Reiterated by Maxim Group $8.80 $22.00
2020-08-11 Buy Initiated by Jefferies Financial Group $12.06 $19.00
2020-08-06 Buy Reiterated by HC Wainwright $12.08 $30.00
2020-05-14 Buy Reiterated by Maxim Group $17.70 $30.00
2020-04-14 Buy Initiated by Brookline Capital Management $12.96 $35.00

BLPH Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -16.79% during the next 3 months and, with a 90% probability hold a price between $2.82 and $3.85 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $3.38 $3.99 $4.61
2021-09-23 $3.37 $3.98 $4.59
2021-09-24 $3.35 $3.96 $4.58
2021-09-27 $3.34 $3.95 $4.56
2021-09-28 $3.32 $3.93 $4.55
2021-09-29 $3.31 $3.92 $4.53
2021-09-30 $3.29 $3.90 $4.52
2021-10-01 $3.28 $3.89 $4.50
2021-10-04 $3.26 $3.88 $4.49
2021-10-05 $3.25 $3.86 $4.47
2021-10-06 $3.23 $3.85 $4.46
2021-10-07 $3.22 $3.83 $4.44
2021-10-08 $3.20 $3.82 $4.43
2021-10-11 $3.19 $3.80 $4.41
2021-10-12 $3.17 $3.79 $4.40
2021-10-13 $3.16 $3.77 $4.38
2021-10-14 $3.14 $3.76 $4.37
2021-10-15 $3.13 $3.74 $4.36
2021-10-18 $3.11 $3.73 $4.34
2021-10-19 $3.10 $3.71 $4.33
2021-10-20 $3.08 $3.70 $4.31
2021-10-21 $3.07 $3.68 $4.30
2021-10-22 $3.05 $3.67 $4.28
2021-10-25 $3.04 $3.65 $4.27
2021-10-26 $3.02 $3.64 $4.25
2021-10-27 $3.01 $3.62 $4.24
2021-10-28 $3.00 $3.61 $4.22
2021-10-29 $2.98 $3.59 $4.21
2021-11-01 $2.97 $3.58 $4.19
2021-11-02 $2.95 $3.56 $4.18

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates include INOpulse, a pulsatile nitric oxide delivery device, which has completed Phase II clinical trials for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trials... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT